• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Strategies for the design of potent and selective kinase inhibitors.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Strategies for the design of potent and selective kinase inhibitors.

Strategies for the design of potent and selective kinase inhibitors. Curr Pharm Des. 2005; 11(14):1845-63.

View in: PubMed

subject areas
  • Adenosine Triphosphate
  • Animals
  • Benzamides
  • Binding Sites
  • CDC2 Protein Kinase
  • CDC2-CDC28 Kinases
  • Crystallography, X-Ray
  • Cyclic AMP-Dependent Protein Kinases
  • Cyclin-Dependent Kinase 2
  • Drug Design
  • ErbB Receptors
  • Humans
  • Imatinib Mesylate
  • Intracellular Signaling Peptides and Proteins
  • Magnetic Resonance Spectroscopy
  • Mitogen-Activated Protein Kinase 10
  • p38 Mitogen-Activated Protein Kinases
  • Phosphorylation
  • Piperazines
  • Protein Binding
  • Pyrimidines

authors with profiles
  • Campbell McInnes